Back to search

Article

Health Professionals’ Preferences With the Use of Pegfilgrastim On-Body Injector At Oncology Centers in 8 Cities in Colombia.

2021-10-19

Abstract excerpt

<title>Abstract</title> <p>Purpose Febrile neutropenia associated with some chemotherapy regimens can lead to potentially fatal complications and high health care costs. Administration of Pegfilgrastim 27 hours after chemotherapy, using an On-Body Injector (OBI), may be more convenient for cancer patients and physicians. This study aims to describe physician and nurse preferences regarding options for administra...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7ddf7e0c-2f7a-5df3-898d-bad61c1f3c84
DOI
10.21203/rs.3.rs-884204/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Health Professionals’ Preferences With the Use of Pegfilgrastim On-Body Injector At Oncology Centers in 8 Cities in Colombia.DOI 10.21203/rs.3.rs-884204/v1
Anticancer Drug Utilization and Prescription Practices in a Saudi Cancer Center (2014-2022)Semantic proximity
Patients' Attitudes towards Switching to National Volume-Based Procurement (NVBP) Drugs -A Qualitative Investigation in Wuhan, ChinaSemantic proximity
Current practices, challenges, and future directions in subcutaneous oncology monoclonal antibody delivery: A qualitative studySemantic proximity
Guide for recommendations on specific drug-related off-label treatment in palliative care: A Group Delphi processSemantic proximity
Subcutaneous immunoglobulin replacement therapy in patients with immunodeficiencies – impact of drug packaging and administration method on patient-reported outcomesSemantic proximity
Patient and Healthcare Professional Experience with Fixed-Dose Subcutaneous Pertuzumab and Trastuzumab (PHESGO) in a High-Volume Oncology Center in Vietnam: A Real-World Study from a Resource-Constrained SettingSemantic proximity
Decision making in the end-of-life care of patients who are terminally ill with cancer – a qualitative descriptive study with a phenomenological approach from the experience of healthcare workers.Semantic proximity
More than “hematology”: A qualitative study on the experience of hematologists treating people with blood cancer in GreeceSemantic proximity
Treatment preferences towards thrombopoietin-receptor agonists for immune thrombocytopenia and experience of disease (TRAPeze): Italy cohortSemantic proximity
Patient Preferences for Treatment‑Free Intervals in Multiple Myeloma: Mixed‑Methods Insights on Monitoring Trade‑offs and Supportive Care ImprovementsSemantic proximity
The impact of training chemotherapy safety standards with a smartphone application on the knowledge, attitude, and performance of nursesSemantic proximity
From Implicit Participation to Integration: The Evolving Role of Nurses in OncofertilitySemantic proximity
Select a neighboring publication to make it the new centre.